GLP-1 drugs associated with reduced need for emergency care for migraine
Drugs also related to lower use of drugs to stop, prevent attacksHighlights:For people with chronic migraine, starting GLP-1 drugs for...
Drugs also related to lower use of drugs to stop, prevent attacksHighlights:For people with chronic migraine, starting GLP-1 drugs for...
AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck, a digital platform for cognitive assessment and care, today announced that it has raised...
The Global Alzheimer’s Platform Foundation’s® (GAP) 2025 Citizen Scientist Award® recipients announced in Las VegasWASHINGTON, Feb. 27, 2026 (GLOBE NEWSWIRE)...
Highlights:A new review of research has found the number of parents refusing vitamin K injections for their newborns is on...
The partnership integrates high-resolution multi-omics data generation with predictive multimodal machine learning to support biopharma decision-making in neurology.SALT LAKE CITY,...
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD),...
The grant will provide selected biotech companies with comprehensive epiproteomic profiling and expert analysis to support critical translational decision-makingNEW YORK,...
PITTSBURGH, Feb. 20, 2026 /PRNewswire/ -- Cardiac experts from Pittsburgh's Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) announced today they...
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Tennr today announced that Dr. William H. Morris, former Cleveland Clinic and Google executive, has...
SAN FRANCISCO, Feb. 17, 2026 /PRNewswire/ -- SamaCare, the leading prior authorization platform for medical benefit drugs, today announced that...
BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform...
During year 5 of treatment with BRIUMVI the annualized relapse rate was 0.020, equivalent to one relapse occurring every 50...
BLUE BELL, Pa., Feb. 11, 2026 /PRNewswire/ -- Elevate Healthcare Marketing, a leading healthcare marketing agency known for delivering insight-driven,...
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
Members of the SEISMIC project team Members of the SEISMIC project team SEISMIC Kickoff Meeting at Philips in Best, the...
Surge in the prevalence of chronic diseases such as cancer & cardiovascular diseases and advancements in technology drive the growth...
Two-Day Forum Offers an Opportunity to Network with Industry Leaders Exploring Neurotech Investment OpportunitiesInnovative companies advancing neurotechnology, including BCI, neuromodulation,...
Acquisition strengthens the group's portfolio with expertise in high-science and evidence-driven strategy and creative DALLAS, Feb. 10, 2026 /PRNewswire/ --...
BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on...